Clinical course and prognostic indicators in patients presenting with back and leg pain in primary care
Not Applicable
Completed
- Conditions
- Musculoskeletal diseaseMusculoskeletal DiseasesBack and leg pain
- Registration Number
- ISRCTN75555299
- Lead Sponsor
- niversity of Keele (UK)
- Brief Summary
2012 protocol in https://pubmed.ncbi.nlm.nih.gov/22264273/ (added 07/09/2020)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
1. Previous participants in the ATLAS study
2. Target Gender: Male & Female
Exclusion Criteria
1. Withdrawn or excluded from the ATLAS study
2. Declined further contact for research purposes at their 12-month follow-up questionnaire
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in the RMDQ (Roland and Morris Disability Questionnaire using the leg pain version): defined as a change of at least 30% improvement in an individual's RMDQ score (Jordan et al., 2006). This will be measured at 3, 4 and 5 years.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie chronic back and leg pain in primary care patients as studied in ISRCTN75555299?
How does the ATLAS cohort compare to standard-of-care outcomes for musculoskeletal pain management over 5 years?
Are there specific biomarkers identified in ISRCTN75555299 that predict prognosis for patients with radiculopathy or sciatica?
What adverse events are associated with long-term management strategies for back and leg pain in primary care settings?
What combination therapies show improved efficacy for musculoskeletal pain compared to the observational findings in the ATLAS study?